Mylan Demands FDA Response To Petition On "Branded Generics"
U.S. generic drug maker Mylan Laboratories has supplemented a petition with the U.S. Food and Drug Administration, seeking an immediate response to its claim that branded drugmakers are unfairly undermining sales...To view the full article, register now.
Already a subscriber? Click here to view full article